TNFSF13B and systemic lupus erythematosus: So far, type I IFNs have been implicated in a loss of tolerance, the activation of neutrophils and the release of neutrophil extracellular traps (NETs), the production of the B-cell activating factor (BAFF), and other events; nevertheless, our understanding of the pathophysiology of SLE is still incomplete [4].